Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants

Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants

Item
http://www.wikidata.org/entity/Q28367570
Structural and Inhibition Studies of the RNase H Function of Xenotropic Murine Leukemia Virus-Related Virus Reverse TranscriptaseResistance pattern of human immunodeficiency virus type 1 reverse transcriptase to quinoxaline S-2720Differential activities of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives against different human immunodeficiency virus type 1 mutant strainsThe nucleoside analog-resistant E89G mutant of human immunodeficiency virus type 1 reverse transcriptase displays a broader cross-resistance that extends to nonnucleoside inhibitorsGenotypic testing for human immunodeficiency virus type 1 drug resistance.The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT.In search of a selective antiviral chemotherapy.Effect of mutations at position E138 in HIV-1 reverse transcriptase and their interactions with the M184I mutation on defining patterns of resistance to nonnucleoside reverse transcriptase inhibitors rilpivirine and etravirine.HIV-1 Protease and reverse-transcriptase mutations: correlations with antiretroviral therapy in subtype B isolates and implications for drug-resistance surveillanceThe Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors.Amino acid substitutions at position 190 of human immunodeficiency virus type 1 reverse transcriptase increase susceptibility to delavirdine and impair virus replication.TMC125 displays a high genetic barrier to the development of resistance: evidence from in vitro selection experiments.Characterization of novel non-nucleoside reverse transcriptase (RT) inhibitor resistance mutations at residues 132 and 135 in the 51 kDa subunit of HIV-1 RT.Antiviral activity of 4-benzyl pyridinone derivatives as HIV-1 reverse transcriptase inhibitors.
P2860

Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants

Item
http://www.wikidata.org/entity/Q28367570
description
1994 nî lūn-bûn
@nan
1994 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Human immunodeficiency virus 1 ...... Y181C-->C181I)RT HIV-1 mutants
@ast
Human immunodeficiency virus 1 ...... Y181C-->C181I)RT HIV-1 mutants
@en
Human immunodeficiency virus 1 ...... Y181C-->C181I)RT HIV-1 mutants
@nl
type
label
Human immunodeficiency virus 1 ...... Y181C-->C181I)RT HIV-1 mutants
@ast
Human immunodeficiency virus 1 ...... Y181C-->C181I)RT HIV-1 mutants
@en
Human immunodeficiency virus 1 ...... Y181C-->C181I)RT HIV-1 mutants
@nl
prefLabel
Human immunodeficiency virus 1 ...... Y181C-->C181I)RT HIV-1 mutants
@ast
Human immunodeficiency virus 1 ...... Y181C-->C181I)RT HIV-1 mutants
@en
Human immunodeficiency virus 1 ...... Y181C-->C181I)RT HIV-1 mutants
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Human immunodeficiency virus 1 ...... Y181C-->C181I)RT HIV-1 mutants
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932